Inactive
Notice ID:FDA-75F40123Q00248
The purpose of Amendment 0001 is to dissolve the Small Business set-aside and re-release this action as full and open. FAR clause 52.212-5 is amended accordingly. All othere terms and conditions remai...
The purpose of Amendment 0001 is to dissolve the Small Business set-aside and re-release this action as full and open. FAR clause 52.212-5 is amended accordingly. All othere terms and conditions remain unchanged. Please refer to documents RFQ_7540123Q00248_Amendment 01 and RFQ_7540123Q00248_SF30_0001 for further details. ---------------------------------------------------------------------- The U.S. Food and Drug Administration (FDA), has a need to procure one (1 each) single particle tracking light obscuration instrument for quantifying subvisible particulate matter in parenteral products in accordance with USP 787, 788, and 789 compliance. BRAND NAME OR EQUAL TO the Accusizer A7000SIS. Please refer to the attached for detailed specifications and instructions regarding the subject procurement.